| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5a16cf30c71a0ca66ee09513f7fc068 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-206 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate |
2002-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b3f19999a94a37a7db304344f0dbb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e75d31b0737dbead555e3e1682c4a04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12e74cb5f7d99c9b9596b8ebc7bdc19b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f04409030b77d4880d9f8bb05559d0e |
| publicationDate |
2003-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20030033950-A |
| titleOfInvention |
Arteriosclerosis inhibitory agent comprising cytoplasmic fraction or debris derived from lactic acid bacteria as an active ingredient |
| abstract |
The present invention relates to an atherosclerosis inhibitor comprising a lactic acid bacteria cytoplasmic fraction or lactic acid bacteria lysate as an active ingredient, and more particularly, an artery capable of preventing and treating atherosclerosis by regulating plasma lipid content, lipid peroxidation and production of inflammatory precursors. It relates to a cure inhibitor. The arteriosclerosis inhibitors according to the present invention are effective arteries because they reduce plasma total cholesterol content, increase HDL-cholesterol content, decrease LDL-cholesterol content, inhibit lipid peroxidation, and inhibit the production of inflammatory precursors. It can be used as a prophylactic and therapeutic agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100592717-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100801556-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101104179-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101426276-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100868777-B1 |
| priorityDate |
2001-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |